SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000116
Filing Date
2021-11-10
Accepted
2021-11-10 16:35:10
Documents
49
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-20211110.htm   iXBRL 8-K 38708
2 EX-99.1 phasebio_q32021financialsx.htm EX-99.1 77049
3 EX-99.2 phasebiocorporateovervie.htm EX-99.2 49810
7 GRAPHIC phasebiocorporateovervie001.jpg GRAPHIC 67618
8 GRAPHIC phasebiocorporateovervie002.jpg GRAPHIC 190697
9 GRAPHIC phasebiocorporateovervie003.jpg GRAPHIC 145652
10 GRAPHIC phasebiocorporateovervie004.jpg GRAPHIC 111782
11 GRAPHIC phasebiocorporateovervie005.jpg GRAPHIC 35467
12 GRAPHIC phasebiocorporateovervie006.jpg GRAPHIC 128529
13 GRAPHIC phasebiocorporateovervie007.jpg GRAPHIC 109584
14 GRAPHIC phasebiocorporateovervie008.jpg GRAPHIC 71746
15 GRAPHIC phasebiocorporateovervie009.jpg GRAPHIC 47397
16 GRAPHIC phasebiocorporateovervie010.jpg GRAPHIC 141083
17 GRAPHIC phasebiocorporateovervie011.jpg GRAPHIC 96982
18 GRAPHIC phasebiocorporateovervie012.jpg GRAPHIC 123126
19 GRAPHIC phasebiocorporateovervie013.jpg GRAPHIC 112497
20 GRAPHIC phasebiocorporateovervie014.jpg GRAPHIC 127863
21 GRAPHIC phasebiocorporateovervie015.jpg GRAPHIC 141716
22 GRAPHIC phasebiocorporateovervie016.jpg GRAPHIC 152058
23 GRAPHIC phasebiocorporateovervie017.jpg GRAPHIC 134219
24 GRAPHIC phasebiocorporateovervie018.jpg GRAPHIC 120439
25 GRAPHIC phasebiocorporateovervie019.jpg GRAPHIC 132364
26 GRAPHIC phasebiocorporateovervie020.jpg GRAPHIC 149121
27 GRAPHIC phasebiocorporateovervie021.jpg GRAPHIC 136553
28 GRAPHIC phasebiocorporateovervie022.jpg GRAPHIC 154567
29 GRAPHIC phasebiocorporateovervie023.jpg GRAPHIC 136549
30 GRAPHIC phasebiocorporateovervie024.jpg GRAPHIC 104626
31 GRAPHIC phasebiocorporateovervie025.jpg GRAPHIC 109477
32 GRAPHIC phasebiocorporateovervie026.jpg GRAPHIC 102980
33 GRAPHIC phasebiocorporateovervie027.jpg GRAPHIC 58741
34 GRAPHIC phasebiocorporateovervie028.jpg GRAPHIC 96205
35 GRAPHIC phasebiocorporateovervie029.jpg GRAPHIC 112845
36 GRAPHIC phasebiocorporateovervie030.jpg GRAPHIC 112862
37 GRAPHIC phasebiocorporateovervie031.jpg GRAPHIC 120132
38 GRAPHIC phasebiocorporateovervie032.jpg GRAPHIC 51023
39 GRAPHIC phasebiocorporateovervie033.jpg GRAPHIC 145274
40 GRAPHIC phasebiocorporateovervie034.jpg GRAPHIC 123159
41 GRAPHIC phasebiocorporateovervie035.jpg GRAPHIC 59952
  Complete submission text file 0001169245-21-000116.txt   5807510

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20211110.xsd EX-101.SCH 1914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20211110_lab.xml EX-101.LAB 25998
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20211110_pre.xml EX-101.PRE 13731
42 EXTRACTED XBRL INSTANCE DOCUMENT phas-20211110_htm.xml XML 11441
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 211397245
SIC: 2834 Pharmaceutical Preparations